What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of investigation include Pathology, Internal medicine, Breast cancer, Cancer and Cancer research.
Dan H. Moore combines subjects such as Ductal carcinoma and Comparative genomic hybridization with his study of Pathology.
Dan H. Moore interconnects Gastroenterology, Placebo and Oncology in the investigation of issues within Internal medicine.
While the research belongs to areas of Breast cancer, Dan H. Moore spends his time largely on the problem of Lymph node, intersecting his research to questions surrounding Microvessel, Neovascularization and Metastasis.
As part of his studies on Cancer, Dan H. Moore often connects relevant areas like Virus.
His Cancer research research is multidisciplinary, incorporating perspectives in Gene expression profiling, Immunology, Tumor progression, Surgical oncology and Primary tumor.
His most cited work include:
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma (1623 citations)
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (866 citations)
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers (668 citations)
What are the main themes of his work throughout his whole career to date?
Dan H. Moore mainly investigates Breast cancer, Internal medicine, Pathology, Cancer and Oncology.
The study incorporates disciplines such as Cancer research, Gynecology and Disease in addition to Breast cancer.
His biological study spans a wide range of topics, including Carcinogenesis, Immunology and Cell growth.
Dan H. Moore works mostly in the field of Internal medicine, limiting it down to topics relating to Placebo and, in certain cases, Randomized controlled trial.
His research in Pathology intersects with topics in Virus and Comparative genomic hybridization.
His Comparative genomic hybridization study deals with the bigger picture of Chromosome.
He most often published in these fields:
- Breast cancer (26.20%)
- Internal medicine (26.20%)
- Pathology (20.23%)
What were the highlights of his more recent work (between 2004-2019)?
- Breast cancer (26.20%)
- Internal medicine (26.20%)
- Oncology (14.64%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Cancer and Surgery.
His Breast cancer study combines topics from a wide range of disciplines, such as Stage, Cancer research, Surgical oncology and Pathology.
His Internal medicine study combines topics in areas such as Placebo and Gynecology.
In his study, Confidence interval is strongly linked to Proportional hazards model, which falls under the umbrella field of Oncology.
His Cancer research is multidisciplinary, relying on both Statin, Prospective cohort study and Incidence.
Dan H. Moore has included themes like Total Skin-Sparing Mastectomy, Mastectomy, Epidemiology, Melanoma and Disease in his Surgery study.
Between 2004 and 2019, his most popular works were:
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (866 citations)
- Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial (515 citations)
- Does this adult patient have septic arthritis (319 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Dan H. Moore mainly focuses on Breast cancer, Internal medicine, Cancer research, Cancer and Surgery.
The Breast cancer study combines topics in areas such as Surgical oncology and Pathology, Comorbidity.
His Internal medicine study integrates concerns from other disciplines, such as Gynecology and Oncology.
Dan H. Moore has included themes like Cell culture, Cell growth, Gene expression profiling, Immunology and Genotype in his Cancer research study.
The concepts of his Cancer study are interwoven with issues in Statin, Epidemiology, Incidence and Prospective cohort study.
The study incorporates disciplines such as Total Skin-Sparing Mastectomy, Mastectomy, Kidney disease, Renal function and Cohort in addition to Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
